| 08:00 – 08.30 |
Nikolaus Rajewsky, Berlin |
Linear and circular RNAs |
| 08.30 – 09.00 |
Wilhelm Krek, Zurich |
HIF signaling, alternative splicing and fructose metabolism in disease |
| 09.00 – 09.30 |
Elizabeth McNally, Chicago |
Genetic profiling to identify new treatment targets for myopathy |
| 09.30 – 10.00 |
Eckhard Wolf, Munich |
Xenotransplantation – new hope for transplantation medicine? |
| Coffee break |
|
|
| 10.30 – 11.00 |
W-G. Forssmann, Hannover |
The use of human native peptide libraries for the discovery of novel drug candidates |
| 11.00 – 11.30 |
Michele De Luca, Modena |
Combined cell and gene therapy for epidermolysis bullosa |
| 11.30 – 12.00 |
Stefanie Dimmeler, Frankfurt |
Development of RNA therapeutics for cardiovascular disease |
| 12.00 – 12.30 |
Thomas Voit, London |
Gene Therapy of striated muscle disorders |
| Lunch break and posters |
|
|
| 14.00 – 14.30 |
W. Jonathan Lederer, Baltimore |
Subcellular Calcium Signaling in Heart: Mechanisms and Mitochondria |
| 14.30 – 15.00 |
Johannes Backs, Heidelberg |
Moving the target for future heart failure therapy - from CaMKII to HDAC4 |
| 15.00 – 15.30 |
Kari Alitalo, Helsinki |
Translational insights into vascular growth factors |
| 15.30 – 16.00 |
Garret FitzGerald, Philadelphia |
Systemic consequences of the molecular clock |
| Coffee break |
|
|
| 16.30 – 17.00 |
Heribert Schunkert, Munich |
Genetics of coronary artery disease |
| 17.00 – 17.30 |
Howard Jacob, Huntsville |
Precision Medicine: Better Care & Better Research |
| 17.30 – 18.00 |
Michael R. Bristow, Denver |
Pharmacogenomic-based drug development in heart failure |
| 18:00 – 18:30 |
Salim Yusuf, Hamilton |
The polypill and its implications |
| Concluding remarks |
Gerd Hasenfuß, Göttingen |
|
| End of meeting |
|
|
